Skip to main content

Advertisement

Table 2 Clinical characteristics of CD patients in remission or active phase

From: The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn’s disease

  Remission Active P value
Number of patients 9 5  
Gender    
 Male 3 2 0.969
 Female 6 3
Mean age (±SD), yr 28.8 ± 16.8 24.0 ± 8.7 0.898
BMI (±SD), kg/m2 18.6 ± 3.1 20.2 ± 6.3 0.898
CDAI    
  ≥ 150 5 4 0.658
  < 150 4 1
Disease location    
 Ileal type 3 0 0.167
 Ileocolonic type 6 4
 Colonic type 0 1
Induction therapy a    
 5-ASA 6 3  
 Steroid 1 0  
 Azathioprine 2 0  
 Infliximab 8 5  
 Adalimumab 1 0  
 GMA/LCAP 0 0  
AIM (μg/ml)    
 Before treatment    
  Average (±SD) 3.8 ± 3.7 3.3 ± 2.1 0.797
 After treatment    
  Average (±SD) 4.4 ± 5.3 3.1 ± 2.7 0.699
  1. asome treatments overlapped